CIK 0001478320
- Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 270907024
- Phone
- +1 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market sale SVP and General Counsel sold 662 shares at $30.00 ($19,860)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CEO and Chairman sold 11,120 shares at $31.56 ($350,947)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CEO and Chairman sold 22,240 shares at an average $31.24 ($694,778)
- 4 Open-market sale Chief Financial Officer sold 20,000 shares at an average $31.52 ($630,308)
- 4 Open-market sale 10% owner sold 4,912,899 shares at $24.98 ($122,706,039)
- 4 Open-market sale 10% owner sold 4,912,899 shares at $24.98 ($122,706,039)
- 4 Open-market sale CEO and Chairman sold 33,360 shares at an average $30.71 ($1,024,586)
- 4 Open-market sale Director sold 345,000 shares at $26.50 ($9,142,500)
Page 25 of 28 · 544 filings